Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Randomized, Double Blind, Controlled Study of Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women

Authors not listed

Guangdong HuaPeptides Biotechnology Co., Ltd. · 2023

Dysbiosis Human Randomized controlled trial

Abstract

The goal of this clinical trial is to study the efficacy of collagen supplement on the moisture content and elasticity. 70 participants of 30-50 years old women will be enrolled from two study sites and randomly assigned to use two products (study product plus collagen supplement and placebo product without collagen supplement) for 2 months. Researchers will compare the two groups to validate the assumption that there is significant improvement on skin anti-aging effect for participants using study product plus collagen supplement.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-29 MST

Cite this

APA

Anonymous. (2023). A Randomized, Double Blind, Controlled Study of Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women. <em>Guangdong HuaPeptides Biotechnology Co., Ltd.</em>. https://clinicaltrials.gov/study/NCT05670977

Vancouver

Anonymous. A Randomized, Double Blind, Controlled Study of Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women. Guangdong HuaPeptides Biotechnology Co., Ltd.. 2023.

BibTeX

@misc{anon2023ARando, title = {A Randomized, Double Blind, Controlled Study of Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women}, author = {Anonymous}, journal = {Guangdong HuaPeptides Biotechnology Co., Ltd.}, year = {2023}, }